USPTO serial 97299949
PROPHET
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- SINGH, DEEP K
- Law office
- TMEG LAW OFFICE 101
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with PROPHET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Birmingham, AL
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Data automation and collection service using proprietary software to evaluate, analyze and collect service data; Data conversion of computer program data or information, other than physical conversion; Data conversion of computer programs and data, not physical conversion; Data conversion of electronic information; Data decryption services; Data encryption and decoding services; Data encryption services; Data encryption services for providing security and anonymity for electronically transmitted credit card transactions; Data migration services; Data mining; Data security consultancy; Data warehousing; Data-acquisition and collection for calibration and coordinate-measurement purposes; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Advanced product research in the field of artificial intelligence; Application service provider (ASP) featuring software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Application service provider, namely, hosting, managing, developing, and maintaining applications, software, and web sites, in the fields of personal productivity, wireless communication, mobile information access, and remote data management for wireless delivery of content to handheld computers, laptops and mobile electronic devices; Authentication of data in the field of biotechnology, pharmaceutical, oncology, medical/health records using blockchain technology; Backup services for computer hard drive data; Cloud storage services for electronic data; Compiling data for research purposes in the field of medical science and medical consultancy; Computer compatibility services, namely, data mapping; Computer programming services for data processing; Computer security threat analysis for protecting data; Computer services in the nature of customized web pages and other data feed formats featuring user-defined information; Computer services, namely, data recovery services; Computer services, namely, encrypted data recovery services; Computer services, namely, on-line scanning, detecting, quarantining and eliminating of viruses, worms, trojans, spyware, adware, malware and unauthorized data and programs on computers and electronic devices; Computer services, namely, providing search engines for obtaining data on a global computer network; Computer services, namely, providing virtual and non virtual application servers, web servers, file servers, co-location servers, load balancing servers, redundancy servers, media servers and database servers of variable capacity to third party computing and data storage facilities; Conducting early evaluations in the field of new pharmaceuticals; Consultancy in the field of artificial intelligence technology; Consulting services in the field of pharmaceutical research; Consulting services in the field of pharmaceutical research and development; Conversion of data or documents from physical to electronic media; Conversion of computer programs and data, other than physical conversion; Design and development of computer software for biotechnology, pharmaceutical, oncology, medical/health records; Design and development of electronic data security systems; Design and development of integrated data collection and wireless transmission hardware systems for equipment and for software applications associated with that equipment at mining, construction, and industrial sites; Design and development of software and hardware for data and multimedia content conversion from and to different protocols; Design and development of software and hardware for multimedia data storing and recalling; Design and development of wireless communication systems for transmission and reception of voice, data and video; Design of information graphics and data visualization materials; Developing customized web pages and other data feed formats featuring user-defined information; Developing customized web pages and other data feed formats featuring user-defined information in the field of biotechnology, pharmaceutical, oncology, medical/health records; Development and creation of computer programmes for data processing; Development of pharmaceutical preparations and medicines; Development of computer programs recorded on data media (software) designed for use in construction and automated manufacturing (cad/cam); Digital compression of computer data; Digital compression of biotechnology, pharmaceutical, oncology, medical/health records data; Digital enhancement and manipulation of radiological data by means of computerized software for use in the field of biotechnology, pharmaceutical, oncology, medical/health services; Document data transfer from one computer format to another; Electronic data back-up services; Electronic data storage; Electronic monitoring and reporting of biotechnology, pharmaceutical, oncology, medical/health records data using computers or sensors; Electronic monitoring of biotechnology, pharmaceutical, oncology, medical/health records data using computers and sensors; Electronic storage of electronic media, namely, images, text and audio data; Electronic storage of biotechnology, pharmaceutical, oncology, medical/health records data; Electronic storage services for archiving databases, images and other electronic data; Electronic storage services for archiving electronic data; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research in the field of oncology; Medical research services in the field of cancer; Pharmaceutical products development; Pharmaceutical research and development; Providing a website featuring non-downloadable software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing information about medical research in the field of biotechnology, pharmaceutical, oncology, medical/health records; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Providing on-line non-downloadable software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of on-line non-downloadable cloud computing software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of on-line non-downloadable software and applications using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Providing temporary use of online non-downloadable chatbot software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Rental of humanoid robots with artificial intelligence; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of artificial intelligence; Research in the field of artificial intelligence technology; Research on the subject of pharmaceuticals; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of biotechnology, pharmaceutical, oncology, medical/health records; Software as a service (SAAS) services featuring software using artificial intelligence for biotechnology, pharmaceutical, oncology, medical/health records; Technical consulting in the field of artificial intelligence (AI) software customization; Technical consulting in the field of pharmaceutical studies; Technical consulting in the field of monitoring technological functions of humanoid robots with artificial intelligence; Technical research in the field of pharmaceutical studies; Technology consultation in the field of artificial intelligence; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | Nov 1, 2021 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2024 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 13, 2024 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 12, 2024 | RDX3 | NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED | — |
| Aug 12, 2024 | RDX1 | ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED | — |
| Aug 12, 2024 | RRDX | ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED | — |
| Apr 24, 2024 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Apr 24, 2024 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Apr 24, 2024 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 27, 2024 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jan 27, 2024 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 27, 2024 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 3, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 3, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 2, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 2, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 2, 2024 | NREV | NOTICE OF REVIVAL - E-MAILED | — |
| Jan 2, 2024 | PETG | PETITION TO REVIVE-GRANTED | — |
| Jan 2, 2024 | PROA | TEAS PETITION TO REVIVE RECEIVED | — |
| Dec 5, 2023 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 4, 2023 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Dec 4, 2023 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Aug 17, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 17, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 19, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 19, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 18, 2023 | ALIE | ASSIGNED TO LIE | — |
| Mar 14, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 3, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 3, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 16, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 11, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 10, 2022 | NWAP | NEW APPLICATION ENTERED | — |